My research interests lie in using the methods of experimental psychopathology and clinical cognitive neuroscience to understand the etiology and development of schizophrenia. I have particular interest in cognitive and behavior markers (i.e. endophenotypes and biomarkers) that can be used to predict conversion to psychosis and psychotic relapse; schizotypy and schizotypal psychopathology in children, adolescents, and adults; the nature of task performance in compensated and decompensated schizotypes; and the impact of cognitive remediation on samples of youth at-risk for serious psychopathology. Currently, I am engaged in research projects exploring the use of electroretinography in serious mental health and neurological conditions, and a NJ DMHAS funded project aimed at developing a novel treatment package to prevent the development of substance use disorders in at-risk youth.
I graduated from Cornell University with a B.S. in Human Development in 2005 and Binghamton University with a Ph.D. in Clinical Psychology in 2012. My graduate advisor was Dr. Mark F. Lenzenweger. I completed my pre-doctoral internship on the Division of Schizophrenia Research track in the Department of Psychiatry at the University of Medicine and Dentistry of New Jersey—Robert Wood Johnson Medical School. My internship mentor was Dr. Steven M. Silverstein. I completed a three-year NIH INSPIRE (IRACDA) postdoctoral fellowship at the University of Medicine and Dentistry of New Jersey—Robert Wood Johnson Medical School with appointments in the Department of Molecular Genetics and Microbiology and the Division of Schizophrenia Research. My post-doctoral mentor was Dr. Silverstein. I am currently a Research Specialist in the Division of Schizophrenia Research at Rutgers University.